Formats
  1. Journal Article (67678)
  2. Meeting Abstract (34145)
  3. Book Section (5156)
  4. Review (3962)
  5. Editorial (2310)
  6. Conference Paper (1529)
  7. Guidelines (705)
  8. Correspondence (696)
  9. Research Letter (577)
  10. Miscellaneous (363)
  11. Book Whole (348)
Groups
  1. Department of Medicine (39735)
  2. GSK Faculty (22753)
  3. Solid Tumor Oncology Division (22407)
  4. Surgery (21574)
  5. Survivorship Research (16029)
  6. Sloan Kettering Institute Faculty (15770)

More Groups

People
  1. Marc Ladanyi (1336)
  2. Robert Motzer (1252)
  3. Victor Reuter (1234)
  4. Howard Scher (1133)
  5. Sergio Giralt (1069)
  6. Murray Brennan (1060)

More People

Years
  1. 2026 (12)
  2. 2025 (3709)
  3. 2024 (5629)
  4. 2023 (5810)
  5. 2022 (6175)
  6. 2021 (5725)

More Years

Publications
  1. Journal of Clinical Oncology (8712)
  2. Blood (5175)
  3. Cancer Research (2705)
  4. International Journal of Radiation Oncology, Biology, Physics (2628)
  5. Laboratory Investigation (1890)
  6. Modern Pathology (1818)

More Publications

Publishers
  1. Elsevier Inc. (12839)
  2. American Society of Clinical Oncology (9323)
  3. Springer (7307)
  4. Nature Publishing Group (6499)
  5. American Association for Cancer Research (6057)
  6. Elsevier Science, Inc. (5578)

More Publishers

Results (117469)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic activity of a bi-specific T cell engaging, TCR-mimic monoclonal antibody to WT1 against human leukemias and cancers in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Dubrovsky, L.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Very high dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia in the setting of intensified anthracycline induction and post stem-cell transplantation
    Meeting Abstract

    Itchaki, G.; Wolach, O.; Bar-Natan, M.; Yeshurun, M.; Ram, R.; Herscovici, C.; Douer, D.; Tallman, M.; Shpilberg, O.; Raanani, P.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia
    Meeting Abstract

    Pagel, J. M.; Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Prognostic significance of survivin expression in patients with diffuse large B-cell lymphoma treated with R-CHOP therapy: A report from the International DLBCL Rituximab-CHOP Consortium Program
    Meeting Abstract

    Liu, Z. Y.; Xu-Monette, Z. Y.; Cao, X.; Visco, C.; Tzankov, A.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y. L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from The International DLBCL Rituximab-CHOP Consortium Program
    Meeting Abstract

    Shen, Q.; Xu-Monette, Z. Y.; Manyam, G. C.; Visco, C.; Tzankov, A.; Cao, X.; Deng, L. J.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Clinical description of acute promyelocytic leukemia (APL) patients receiving all-trans retinoic acid (ATRA) who develop pseudotumor cerebri: Incidence, diagnosis, outcomes, and recommendations for management
    Meeting Abstract

    Coombs, C. C.; DeAngelis, L. M.; Feusner, J. H.; Tallman, M. S.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • Circulating tumor DNA (ctDNA) analysis of PIK3CA and AKT1 mutations in patients enrolled onto the Phase 1b study of the PI3K inhibitor taselisib (GDC-0032) in solid malignancies
    Meeting Abstract

    Wilson, T. R.; Savage, H.; Aimi, J.; Jin, J.; Parmar, H.; Hsu, J.; Krop, I.; Saura, C.; Cervantes, A.; Sachdev, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Comprehensive pan-genomic characterization of adrenocortical carcinoma
    Meeting Abstract

    Zheng, S.; Cherniack, A. D.; Dewal, N.; Moffitt, R. A.; Danilova, L.; Murray, B. A.; Lerario, A. M.; Else, T.; Knijnenburg, T. A.; Ciriello, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Adoptive T cell therapy with CAR modified T cells: We have a model A Ford, can we build a Ferrari?
    Meeting Abstract

    Brentjens, R.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Molecular profiling of immune activation associated with melanoma regression induced by diphencyprone
    Meeting Abstract

    Gulati, N.; Coit, D. G.; Fuentes-Duculan, J.; Gilleaudeau, P.; Sullivan-Whalen, M.; Suarez-Farinas, M.; Krueger, J. G.
    Cancer Research (2015)

    Fulltext@MSK | Save